Power your health
Di&Care is a French company dedicated to the development and commercialization of ‘digital therapeutics’ in the field of sleep and mental health. Our treatments are based on the gold standard therapies in the management of these conditions.
AN INNOVATIVE PROJECT FOR THE BENEFIT OF PATIENTS
Our treatment is based on the European gold standard therapy for managing chronic insomnia: Cognitive Behavioral Therapy (CBT). Noxxea© will be the only solution to integrate Cognitive Behavioral Therapy (CBT), as well as digital phenotyping, which will allow for optimized individualization of the treatment.
Cognitive Behavioral Therapy (CBT) is the gold standard treatment for many other psychiatric conditions such as anxiety disorders, phobic disorders, and depression. Once again, digital phenotyping will optimize treatment individualization with the goal of more effectively treating these patients
The Noxxea© project aims to develop a Digital Cognitive Behavioral Therapy accessible to everyone
Did you know ?
According to the WHO, one in eight people worldwide is living with a mental disorder. Among the profiles of patients with deteriorated mental health, we find working individuals aged 35 to 49 suffering from daily sleep disorders and anxiety.
ABOUT
Who are we ?
Di&Care was founded by two pharmacists holding a University Diploma in ‘Sleep and its Pathology.’ With 15 years of management experience in the healthcare industries, our ambition is to develop innovative digital solutions in the field of mental health.
This project is supported by BPI and an anchorage in the Hauts de France within the Eurasanté incubator in Lille ensures a vision oriented towards Europe.